Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for A.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
July 31, 2026 471.00M
April 30, 2026 -144.00M
January 31, 2026 -222.00M
October 31, 2025 -200.00M
July 31, 2025 -219.00M
April 30, 2025 -116.00M
January 31, 2025 -180.00M
October 31, 2024 25.00M
July 31, 2024 -246.00M
April 30, 2024 -291.00M
January 31, 2024 -240.00M
October 31, 2023 -201.00M
July 31, 2023 -322.00M
April 30, 2023 -390.00M
January 31, 2023 -17.00M
October 31, 2022 -341.00M
July 31, 2022 -362.00M
April 30, 2022 -123.00M
January 31, 2022 -546.00M
October 31, 2021 -324.00M
July 31, 2021 -222.00M
April 30, 2021 166.00M
January 31, 2021 -316.00M
October 31, 2020 -269.00M
July 31, 2020 -231.00M
Date Value
April 30, 2020 -156.00M
January 31, 2020 -61.00M
October 31, 2019 497.00M
July 31, 2019 -578.00M
April 30, 2019 -92.00M
January 31, 2019 -122.00M
October 31, 2018 -131.00M
July 31, 2018 -589.00M
April 30, 2018 -114.00M
January 31, 2018 37.00M
October 31, 2017 -106.00M
July 31, 2017 29.00M
April 30, 2017 -67.00M
January 31, 2017 -58.00M
October 31, 2016 -56.00M
July 31, 2016 -110.00M
April 30, 2016 30.00M
January 31, 2016 -132.00M
October 31, 2015 -29.00M
July 31, 2015 -110.00M
April 30, 2015 -101.00M
January 31, 2015 -828.00M
October 31, 2014 561.00M
July 31, 2014 -518.00M
April 30, 2014 -72.00M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Danaher Corp. 7.273B
Thermo Fisher Scientific, Inc. -1.571B
Waters Corp. -124.00M
Illumina, Inc. -129.00M
Revvity, Inc. -23.16M